{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:29:08Z","timestamp":1782512948220,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>Valvular heart diseases (VHD) are becoming a significant problem in the Polish population. Coexistence of chronic kidney disease (CKD) in patients with VHD increases the risk of death and affects further therapeutic strategy.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Aim<\/jats:title>\n<jats:p>Analysis impact of CKD on long-term prognosis in patients with VHD.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Material and methods<\/jats:title>\n<jats:p>The inclusion criteria were met by 1025 patients with moderate and severe VHD. Mean observation time was 2528\u2009\u00b1\u20091454\u00a0days.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The average age of the studied population was 66.75 (SD\u2009=\u200910.34), male gender was dominant 56% (<jats:italic>N<\/jats:italic>\u2009=\u2009579). Severe aortic valve stenosis (AVS) occurred in 28.2%, severe mitral valve insufficiency (MVI) in 20%. CKD occurred in 37.1% (<jats:italic>N<\/jats:italic>\u2009=\u2009380) patients mostly with mitral stenosis (50%, <jats:italic>N<\/jats:italic>\u2009=\u200916) and those with severe MVI (44.8%, <jats:italic>N<\/jats:italic>\u2009=\u200994). During the observational period, 52.7% (<jats:italic>N<\/jats:italic>\u2009=\u2009540) deaths were noted. Increased risk of mortality was associated mostly with age (OR: 1.02, 95% CI: 1.00\u20131.03, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), creatinine (OR:1.27, 95% CI: 1.12\u20131.43, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), CKD (OR: 1.30, 95% CI: 1.17\u20131.44, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), reduced ejection fraction (EF) (OR: 0.98, 95% CI: 0.97\u20130.99, <jats:italic>p<\/jats:italic>\u2009=\u20090.01) and coexisting of AVS (OR: 1.19, 95% CI: 1.04\u20131.35, <jats:italic>p<\/jats:italic>\u2009=\u20090.01).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Mitral valve defects more often than aortic valve defects coexist with chronic kidney disease. Regardless of the stage, chronic kidney disease is an additional factor affecting the prognosis in patients with heart defects. Factors increasing the risk of death were age, creatinine concentration and reduced EF. The monitoring of renal function in patients with VHD should be crucial as well as the implementation of treatment at an early stage.<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s11255-020-02561-4","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T05:29:00Z","timestamp":1594704540000},"page":"2161-2170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of chronic kidney disease on long-term outcome of patients with valvular heart defects"],"prefix":"10.1007","volume":"52","author":[{"given":"\u0141ukasz","family":"Ku\u017ama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-8171","authenticated-orcid":false,"given":"Jolanta","family":"Ma\u0142yszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Bach\u00f3rzewska-Gajewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Maria","family":"Niwi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kurasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Zalewska-Adamiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Ko\u017cuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Dobrzycki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"2561_CR1","unstructured":"World Health Organization\u2014Noncommunicable Diseases (NCD) Country Profiles (2018) https:\/\/www.who.int\/nmh\/countries\/pol_en.pdf?ua=1. Accessed 11 Apr 2020"},{"issue":"3","key":"2561_CR2","first-page":"435","volume":"68","author":"M Chlabicz","year":"2014","unstructured":"Chlabicz M, Chlabicz S, Marcinowicz L, Rogowska-Szadkowska D, Pytel-Krolczuk B, Leszczy\u0144ska K (2014) Outpatient use of systemic antibiotics in Poland: 2004\u20132008. Przegl Epidemiol 68(3):435\u2013547","journal-title":"Przegl Epidemiol"},{"key":"2561_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/s0195-668x(03)00201-x","volume":"24","author":"B Iung","year":"2003","unstructured":"Iung B, Baron G, Butchart EG et al (2003) A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24:1231\u20131243. https:\/\/doi.org\/10.1016\/s0195-668x(03)00201-x","journal-title":"Eur Heart J"},{"key":"2561_CR4","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Falk V, Bax JJ et al (2017) 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739\u20132791. https:\/\/doi.org\/10.1093\/eurheartj\/ehx391","journal-title":"Eur Heart J"},{"key":"2561_CR5","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1089\/jwh.2014.5158","volume":"24","author":"LE Dobson","year":"2015","unstructured":"Dobson LE, Fairbairn TA, Plein S, Greenwood JP (2015) Sex differences in aortic stenosis and outcome following surgical and transcatheter aortic valve replacement. J Womens Health (Larchmt) 24:986\u2013995. https:\/\/doi.org\/10.1089\/jwh.2014.5158","journal-title":"J Womens Health (Larchmt)"},{"key":"2561_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3978\/j.issn.2225-319X.2014.12.11","volume":"4","author":"C Harris","year":"2015","unstructured":"Harris C, Croce B, Phan K (2015) Aortic stenosis. Ann Cardiothorac Surg 4:99. https:\/\/doi.org\/10.3978\/j.issn.2225-319X.2014.12.11","journal-title":"Ann Cardiothorac Surg"},{"key":"2561_CR7","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA et al (2019) Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 139:e840\u2013e878. https:\/\/doi.org\/10.1161\/CIR.0000000000000664","journal-title":"Circulation"},{"issue":"5","key":"2561_CR8","doi-asserted-by":"publisher","first-page":"E1364","DOI":"10.3390\/jcm9051364","volume":"9","author":"M Chlabicz","year":"2020","unstructured":"Chlabicz M, Jamio\u0142kowski J, Paniczko M et al (2020) ECG indices poorly predict left ventricular hypertrophy and are applicable only in individuals with low cardiovascular risk. J Clin Med 9(5):E1364. https:\/\/doi.org\/10.3390\/jcm9051364","journal-title":"J Clin Med"},{"key":"2561_CR9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.kint.2019.06.025","volume":"96","author":"TH Marwick","year":"2019","unstructured":"Marwick TH, Amann K, Bangalore S et al (2019) Chronic kidney disease and valvular heart disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 96:836\u2013849. https:\/\/doi.org\/10.1016\/j.kint.2019.06.025","journal-title":"Kidney Int"},{"key":"2561_CR10","doi-asserted-by":"publisher","first-page":"e9804","DOI":"10.1097\/MD.0000000000009804","volume":"97","author":"S Rong","year":"2018","unstructured":"Rong S, Qiu X, Jin X et al (2018) Risk factors for heart valve calcification in chronic kidney. Medicine (Baltimore) 97:e9804. https:\/\/doi.org\/10.1097\/MD.0000000000009804","journal-title":"Medicine (Baltimore)"},{"issue":"2013","key":"2561_CR11","first-page":"1","volume":"3","author":"KDIGO","year":"2012","unstructured":"KDIGO (2012) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(2013):1\u2013150","journal-title":"Kidney Int Suppl"},{"key":"2561_CR12","first-page":"W169","volume":"67","author":"T Hryniewiecki","year":"2009","unstructured":"Hryniewiecki T, St\u0119pi\u0144ska J (2009) WadPol\u2014POLKARD. Og\u00f3lnopolski Rejestr Nabytych Wad Zastawkowych [English POLKARD\u2014National Registry of Valvular Heart Defects]. Kardiol Pol 67:W169","journal-title":"Kardiol Pol"},{"key":"2561_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.7326\/M16-0273","volume":"165","author":"D Murphy","year":"2016","unstructured":"Murphy D, McCulloch CE, Lin F et al (2016) Trends in prevalence of chronic kidney disease in the United States. Ann Int Med 165:473\u2013481. https:\/\/doi.org\/10.7326\/M16-0273","journal-title":"Ann Int Med"},{"key":"2561_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/sj.ki.5002374","volume":"72","author":"JFM Wetzels","year":"2007","unstructured":"Wetzels JFM, Kiemeney LALM, Swinkels DW et al (2007) Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72:632\u2013637. https:\/\/doi.org\/10.1038\/sj.ki.5002374","journal-title":"Kidney Int"},{"key":"2561_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1053\/j.ackd.2014.12.001","volume":"22","author":"E Judd","year":"2015","unstructured":"Judd E, Calhoun DA (2015) Management of hypertension in CKD: BEYOND THE GUIDELINES. Adv Chronic Kidney Dis 22:116\u2013122. https:\/\/doi.org\/10.1053\/j.ackd.2014.12.001","journal-title":"Adv Chronic Kidney Dis"},{"key":"2561_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/ki.2008.261","volume":"74","author":"K Iseki","year":"2008","unstructured":"Iseki K (2008) Gender differences in chronic kidney disease. ISN International Society of Nephrology. Kidney Int 74:415\u2013417. https:\/\/doi.org\/10.1038\/ki.2008.261","journal-title":"Kidney Int"},{"key":"2561_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006044","author":"Z Samad","year":"2017","unstructured":"Samad Z, Sivak JA, Phelan M et al (2017) Prevalence and outcomes of left-sided valvular heart disease associated with chronic kidney disease. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.117.006044","journal-title":"J Am Heart Assoc"},{"key":"2561_CR18","unstructured":"Ancona R, Pinto SC (2018) Mitral valve incompetence: epidemiology and causes. E-J Cardiol Pract 16(11)"},{"key":"2561_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rmcr.2018.03.007","volume":"24","author":"S Korzan","year":"2018","unstructured":"Korzan S, Jones E, Mutneja R, Grover P (2018) Mitral stenosis due to rheumatic heart disease\u2014a rare cause of massive hemoptysis. Respir Med Case Rep 24:35\u201339. https:\/\/doi.org\/10.1016\/j.rmcr.2018.03.007","journal-title":"Respir Med Case Rep"},{"key":"2561_CR20","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296\u20131305. https:\/\/doi.org\/10.1056\/NEJMoa041031","journal-title":"N Engl J Med"},{"key":"2561_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13019-014-0153-1","volume":"9","author":"ZY Emren","year":"2014","unstructured":"Emren ZY, Emren SV, K\u0131l\u0131\u00e7aslan B et al (2014) Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease. J Cardiothorac Surg 9:153. https:\/\/doi.org\/10.1186\/s13019-014-0153-1","journal-title":"J Cardiothorac Surg"},{"key":"2561_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10554-015-0752-5","volume":"32","author":"L Liyanage","year":"2016","unstructured":"Liyanage L, Lee NJ, Cook T et al (2016) The impact of gender on cardiovascular system calcification in very elderly patients with severe aortic stenosis. Int J Cardiovasc Imaging 32:173\u2013179. https:\/\/doi.org\/10.1007\/s10554-015-0752-5","journal-title":"Int J Cardiovasc Imaging"},{"key":"2561_CR23","doi-asserted-by":"publisher","first-page":"5178631","DOI":"10.1155\/2017\/5178631","volume":"2017","author":"MM Izquierdo-G\u00f3mez","year":"2017","unstructured":"Izquierdo-G\u00f3mez MM, Hern\u00e1ndez-Betancor I, Garc\u00eda-Niebla J et al (2017) Valve calcification in aortic stenosis: etiology and diagnostic imaging techniques. Biomed Res Int 2017:5178631. https:\/\/doi.org\/10.1155\/2017\/5178631","journal-title":"Biomed Res Int"},{"key":"2561_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.amjmed.2016.10.005","volume":"130","author":"J Joseph","year":"2017","unstructured":"Joseph J, Naqvi SY, Giri J, Goldberg S (2017) Aortic stenosis: pathophysiology, diagnosis, and therapy. Am J Med 130:253\u2013263. https:\/\/doi.org\/10.1016\/j.amjmed.2016.10.005","journal-title":"Am J Med"},{"issue":"4","key":"2561_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.5114\/aic.2019.90216","volume":"15","author":"\u0141 Ku\u017ama","year":"2019","unstructured":"Ku\u017ama \u0141, Bach\u00f3rzewska-Gajewska H, Ko\u017cuch M et al (2019) Acute coronary syndromes and atherosclerotic plaque burden distribution in coronary arteries among patients with valvular heart disease (BIA-WAD registry). Postepy Kardiol Interwencyjnej 15(4):422\u2013430. https:\/\/doi.org\/10.5114\/aic.2019.90216","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"2561_CR26","unstructured":"Solomon SD, Wu JC, Gillam L, Bulwer B, Scott D (2019) Echocardiography. In: Braunwald\u2019s heart disease: a textbook of cardiovascular medicine, pp 174\u2013251"},{"key":"2561_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12882-018-0877-6","volume":"19","author":"D Inaguma","year":"2018","unstructured":"Inaguma D, Sasakawa Y, Suzuki N et al (2018) Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis. BMC Nephrol 19:80. https:\/\/doi.org\/10.1186\/s12882-018-0877-6","journal-title":"BMC Nephrol"},{"key":"2561_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3410\/B3-23","volume":"3","author":"A Basseville","year":"2011","unstructured":"Basseville A, Bates SE (2011) Gout, genetics and ABC transporters. F1000 Biol Rep 3:23. https:\/\/doi.org\/10.3410\/B3-23","journal-title":"F1000 Biol Rep"},{"key":"2561_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jare.2017.05.001","volume":"8","author":"T Eleftheriadis","year":"2017","unstructured":"Eleftheriadis T, Golphinopoulos S, Pissas G, Stefanidis I (2017) Asymptomatic hyperuricemia and chronic kidney disease: narrative review of a treatment controversial. J Adv Res 8:555\u2013560. https:\/\/doi.org\/10.1016\/j.jare.2017.05.001","journal-title":"J Adv Res"},{"key":"2561_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11255-015-0939-7","volume":"47","author":"A Bakan","year":"2015","unstructured":"Bakan A, Oral A, Elcioglu OC et al (2015) Hyperuricemia is associated with progression of IgA nephropathy. Int Urol Nephrol 47:673\u2013678. https:\/\/doi.org\/10.1007\/s11255-015-0939-7","journal-title":"Int Urol Nephrol"},{"key":"2561_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/qjmed\/hcu057","volume":"9","author":"AG Stack","year":"2014","unstructured":"Stack AG, Donigiewicz U, Abdalla AA et al (2014) Plasma fibrinogen associates independently with total and cardiovascular mortality among subjects with normal and reduced kidney function in the general population. Int J Med 9:701\u2013713. https:\/\/doi.org\/10.1093\/qjmed\/hcu057","journal-title":"Int J Med"},{"key":"2561_CR32","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1038\/ki.2008.519","volume":"111","author":"M Goicoechea","year":"2008","unstructured":"Goicoechea M, de Vinuesa SG, G\u00f3mez-Campder\u00e1 F (2008) Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4. Kidney Int Suppl 111:S67\u201370. https:\/\/doi.org\/10.1038\/ki.2008.519","journal-title":"Kidney Int Suppl"},{"key":"2561_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.hfc.2013.10.002","volume":"10","author":"A Lala","year":"2014","unstructured":"Lala A, Desai AS (2014) The role of coronary artery disease in heart failure. Heart Fail Clin 10:353\u2013365. https:\/\/doi.org\/10.1016\/j.hfc.2013.10.002","journal-title":"Heart Fail Clin"},{"key":"2561_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","volume":"13","author":"B Ziaeian","year":"2016","unstructured":"Ziaeian B, Fonarow GC (2016) Epidemiology and aetiology of heart failure. Nat Rev Cardiol 13:368\u2013378. https:\/\/doi.org\/10.1038\/nrcardio.2016.25","journal-title":"Nat Rev Cardiol"},{"key":"2561_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A et al (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407\u2013477. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"},{"key":"2561_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5935\/abc.20150080","volume":"105","author":"VEE Rosa","year":"2015","unstructured":"Rosa VEE, Accorsi TAD, Fernandes JRC et al (2015) Low-flow aortic stenosis and reduced ejection fraction: new insights. Arq Bras Cardiol 105:82\u201385. https:\/\/doi.org\/10.5935\/abc.20150080","journal-title":"Arq Bras Cardiol"},{"key":"2561_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fcvm.2018.00111","volume":"5","author":"E Spitzer","year":"2018","unstructured":"Spitzer E, Ren B, Kroon H et al (2018) Moderate aortic stenosis and reduced left ventricular ejection fraction: current evidence and challenges ahead. Front Cardiovasc Med 5:111. https:\/\/doi.org\/10.3389\/fcvm.2018.00111","journal-title":"Front Cardiovasc Med"},{"key":"2561_CR38","doi-asserted-by":"publisher","first-page":"432","DOI":"10.21037\/acs.2017.09.10","volume":"6","author":"A Chakos","year":"2017","unstructured":"Chakos A, Wilson-Smith A, Arora S et al (2017) Long-term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond. Ann Cardiothorac Surg 6:432\u2013443. https:\/\/doi.org\/10.21037\/acs.2017.09.10","journal-title":"Ann Cardiothorac Surg"},{"key":"2561_CR39","doi-asserted-by":"publisher","first-page":"E63","DOI":"10.1002\/ccd.27820","volume":"93","author":"T Attisano","year":"2019","unstructured":"Attisano T, Silverio A, Stabile E et al (2019) Safety and feasibility of balloon aortic valvuloplasty in non-TAVI Centers: the \"BAV for Life\" experience. Catheter Cardiovasc Interv 93:E63\u2013E70. https:\/\/doi.org\/10.1002\/ccd.27820","journal-title":"Catheter Cardiovasc Interv"},{"key":"2561_CR40","doi-asserted-by":"publisher","first-page":"812","DOI":"10.21037\/acs.2018.11.04","volume":"7","author":"A Colli","year":"2018","unstructured":"Colli A, Adams D, Fiocco A et al (2018) Transapical NeoChord mitral valve repair. Ann Cardiothorac Surg 7:812\u2013820. https:\/\/doi.org\/10.21037\/acs.2018.11.04","journal-title":"Ann Cardiothorac Surg"},{"key":"2561_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2018.07.021","volume":"205","author":"MJ Mack","year":"2018","unstructured":"Mack MJ, Abraham WT, Lindenfeld JA et al (2018) Cardiovascular outcomes assessment of the MitraClip in patients with heart failure and secondary mitral regurgitation: design and rationale of the COAPT trial. Am Heart J 205:1\u201311. https:\/\/doi.org\/10.1016\/j.ahj.2018.07.021","journal-title":"Am Heart J"},{"key":"2561_CR42","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/CIRCINTERVENTIONS.113.000650","volume":"6","author":"S Elmariah","year":"2013","unstructured":"Elmariah S, Palacios IF, McAndrew T et al (2013) Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the placement of aortic transcatheter valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv 6:604\u2013614. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.113.000650","journal-title":"Circ Cardiovasc Interv"},{"key":"2561_CR43","doi-asserted-by":"publisher","DOI":"10.1177\/1179065217719023","author":"JV Merwe","year":"2019","unstructured":"Merwe JV, Casselman F (2019) Mitral valve replacement\u2014current and future perspectives. Open J Cardiothorac Surg. https:\/\/doi.org\/10.1177\/1179065217719023","journal-title":"Open J Cardiothorac Surg"},{"key":"2561_CR44","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/s0735-1097(00)01202-x","volume":"37","author":"FH Edwards","year":"2001","unstructured":"Edwards FH, Peterson ED, Coombs LP et al (2001) Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 37:885\u2013892. https:\/\/doi.org\/10.1016\/s0735-1097(00)01202-x","journal-title":"J Am Coll Cardiol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02561-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-020-02561-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02561-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:06:20Z","timestamp":1626221180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-020-02561-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2561"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02561-4","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"19 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"The authors declare that they do not have any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}